Valeant Pharmaceuticals (VRX) Reflexive Behavior In Financial Markets: GS – ValueWalk Premium

Valeant Pharmaceuticals (VRX) Reflexive Behavior In Financial Markets: GS

While all the news is about today's conference call, Goldman takes a look at last week's 'crisis'.

The 35% plunge in Valeant Pharmaceuticals is a classic example of reflexive behavior in financial markets, according to Goldman Sachs.

In a research note issued to clients at the end of last week and reviewed by ValueWalk, Goldman concludes that Valeant's plunge is a perfect example of George Soros' concept of reflexive financial markets, as described in his book,

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
0